| #29 |
John Paul Mathias |
Pfizer |
2 |
| #29 |
David Barash |
Zoll Medical |
2 |
| #53 |
Paul A. DeBitetto |
Draper Laboratory |
1 |
| #53 |
Jason Boke Wright |
Homology Medicines |
1 |
| #53 |
Bruce A. Zimmerman |
Emc Ip Holding Company |
1 |
| #53 |
Timothy Webb |
Cisco |
1 |
| #53 |
Philip Charles Walker |
Dots Technology |
1 |
| #53 |
Mattan Kamon |
Coventor |
1 |
| #53 |
Sonal Chatter |
— |
1 |
| #53 |
James Stephen Holden |
Netapp |
1 |
| #53 |
Raymond Ferrara |
Musculoskeletal Transplant Foundation |
1 |
| #53 |
Robert Pitha |
Grey Orange Pte. |
1 |
| #53 |
David Cook |
Coulter Electronics |
1 |
| #53 |
Christina Scherer |
Kineta Two |
1 |
| #53 |
Lucien Alfred Couvillon, Jr. |
Boston Scientific Scimed |
1 |
| #53 |
Monica C. Wong-Chan |
Oracle |
1 |
| #53 |
Zachary W. Arnold |
Emc Ip Holding Company |
1 |
| #53 |
Timothy Hellman |
Broadcom |
1 |
| #53 |
Martyn Botfield |
Vertex Pharmaceuticals Incorporated |
1 |
| #53 |
Mark Edward Bunnage |
Pfizer |
1 |
| #53 |
Bruce J. Walker |
Compaq Computer |
1 |
| #53 |
Ehab Hamed |
Cima Labs |
1 |
| #53 |
Gary Lewis Bloomgren |
Biogen Ma |
1 |
| #53 |
Basak Ulker Karbeyaz |
— |
1 |
| #53 |
Frank C. Robey |
MIT |
1 |
| #53 |
Scott Michael Brazina |
Dynamic Network Services. |
1 |
| #53 |
Feiling Wang |
Tomophase |
1 |
| #53 |
Erik L. Waldron |
Draper Laboratory |
1 |
| #53 |
Vivek Garg |
IBM |
1 |
| #53 |
Allan Rubin |
— |
1 |
| #53 |
Thomas C. Tremblay |
Guardair |
1 |
| #53 |
Brian H. Mackintosh |
ExxonMobil |
1 |
| #53 |
David Borsook |
The General Hospital |
1 |
| #53 |
George F. COLONY |
— |
1 |
| #53 |
John Robblee |
Momenta Pharmaceuticals |
1 |
| #53 |
Peter Waksman |
Koniniklijke Philips N.V. |
1 |
| #53 |
Charles Nicholson |
Otto Industries |
1 |
| #53 |
Dafydd Rhys Owen |
Pfizer |
1 |
| #53 |
Howard P. Miller |
Kyra Medical |
1 |
| #53 |
James L. Finnerty |
Amazon |
1 |
| #53 |
Xipeng Liu |
Saint-Gobain Performance Plastics |
1 |
| #53 |
Richard Speer |
Osram Sylvania |
1 |
| #53 |
Robert Penfield |
128 Technology |
1 |
| #53 |
Priti H. Chatter |
Disney |
1 |
| #53 |
Mark T. Buquor |
IBM |
1 |
| #53 |
Adam Morris-Cohen |
Lockheed Martin |
1 |
| #53 |
Reinier Beeuwkes |
Ischemix |
1 |
| #53 |
Edward F. Fritsch |
Genetics Institute |
1 |
| #53 |
Patrick H. Winston |
MIT |
1 |
| #53 |
Lynn Hawkins |
Eisai R&D Management Co. |
1 |